A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

BACKGROUND: The prognosis of acute lymphoblastic leukemia in the elderly is poor. The GRAALL-SA1 phase II, randomized trial compared the efficacy and toxicity of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in patients 55 years or older with Philadelphia chromosome-negative...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hunault-Berger, Mathilde, Leguay, Thibaut, Thomas, Xavier, Legrand, Ollivier, Huguet, Françoise, Bonmati, Caroline, Escoffre-Barbe, Martine, Legros, Laurence, Turlure, Pascal, Chevallier, Patrice, Larosa, Fabrice, Garban, Frederic, Reman, Oumedaly, Rousselot, Philippe, Dhédin, Nathalie, Delannoy, André, Lafage-Pochitaloff, Marina, Béné, Marie Christine, Ifrah, Norbert, Dombret, Hervé
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031692/
https://ncbi.nlm.nih.gov/pubmed/20971822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.027862
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados